David G Mutch (David M Mutch, David Mutch)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Topics

Locally Advanced

Endometrial Cancer

Placebo Controlled

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Molecular cancer research : MCR

Critical reviews in food science and nutrition

This page only lists publications with an associated author ORCID identifier.

Publications

Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
David G Mutch, Athina Voulgari, Xian Marissa Chen, William H Bradley, Ana Oaknin, José Alejandro Perez Fidalgo, Fernando Galvez Montosa, Antonio Casado Herraez, Robert W Holloway, Matthew A Powell, Malgorzata Nowicka, Gabriele Schaefer, Mark Merchant, Yibing Yan
Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer. Cancer (2024)
David G Mutch, Athina Voulgari, Xian Marissa Chen, William H Bradley, Ana Oaknin, José Alejandro Perez Fidalgo, Fernando Galvez Montosa, Antonio Casado Herraez, Robert W Holloway, Matthew A Powell, Malgorzata Nowicka, Gabriele Schaefer, Mark Merchant, Yibing Yan
Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer. Cancer 130 (11) (2024)
David G Mutch, Athina Voulgari, Xian Marissa Chen, William H Bradley, Ana Oaknin, José Alejandro Perez Fidalgo, Fernando Galvez Montosa, Antonio Casado Herraez, Robert W Holloway, Matthew A Powell, Malgorzata Nowicka, Gabriele Schaefer, Mark Merchant, Yibing Yan
Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer. Cancer 130 (11) (2024)
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jonathan S Berek, Xavier M Guiu, Carien L Creutzberg, Christina Fotopoulou, David K Gaffney, Sean Kehoe, Kristina Lindemann, David G Mutch, Nicole Concin, null null
FIGO staging of endometrial cancer: 2023. Journal of gynecologic oncology (2023)
Angela M Schab, Molly M Greenwade, Elizabeth C Stock, Elena Lomonosova, Kevin Cho, Whitney R Grither, Hollie Noia, Daniel Wilke, Mary M Mullen, Andrea R Hagemann, Ian S Hagemann, Premal H Thaker, Lindsay M Kuroki, Carolyn K McCourt, Dineo Khabele, Matthew A Powell, David G Mutch, Peinan Zhao, Leah P Shriver, Gary J Patti, Gregory D Longmore, Katherine C Fuh
Stromal DDR2 promotes ovarian cancer metastasis through regulation of metabolism and secretion of extracellular matrix proteins. Molecular cancer research : MCR (2023)
Sandip Pravin Patel, Megan K D Othus, Young Kwang Chae, Michael J Dennis, Sarah Gordon, David G Mutch, Wolfram E Samlowski, William R Robinson, Elad Sharon, Christopher Ryan, Gabby Lopez, Melissa Plets, Charles David Blanke, Razelle Kurzrock
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in patients with gestational trophoblastic neoplasia. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Amanda J Compadre, Lillian N van Biljon, Mark C Valentine, Alba Llop-Guevara, Emily Graham, Bisiayo Fashemi, Andrea Herencia-Ropero, Emilee N Kotnik, Isaac Cooper, Shariska P Harrington, Lindsay M Kuroki, Carolyn K McCourt, Andrea R Hagemann, Premal H Thaker, David G Mutch, Matthew A Powell, Lulu Sun, Nima Mosammaparast, Violeta Serra, Peinan Zhao, Elena Lomonosova, Dineo Khabele, Mary M Mullen
RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Benoit You, Christopher Purdy, Larry J Copeland, Elizabeth M Swisher, Michael A Bookman, Gini F Fleming, Robert L Coleman, Leslie M Randall, Krishnansu S Tewari, Bradley J Monk, Robert S Mannel, Joan L Walker, Fabio Cappuccini, David E Cohn, Mahvish Muzaffar, David G Mutch, Andrea E Wahner Hendrickson, Lainie Martin, Olivier Colomban, Robert A Burger
Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (34) (2022)
Matthew A Powell, Virginia L Filiaci, Martee L Hensley, Helen Q Huang, Kathleen M Moore, Krishnansu S Tewari, Larry J Copeland, Angeles A Secord, David G Mutch, Alessandro Santin, David P Warshal, Nick M Spirtos, Paul A DiSilvestro, Olga B Ioffe, David Scott Miller
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (9) (2022)
Shaina F Bruce, Kevin Cho, Hollie Noia, Elena Lomonosova, Elizabeth C Stock, Alyssa Oplt, Barbara Blachut, Mary M Mullen, Lindsay M Kuroki, Andrea R Hagemann, Carolyn K McCourt, Premal H Thaker, Dineo Khabele, Matthew A Powell, David G Mutch, Leah P Shriver, Gary J Patti, Katherine C Fuh
GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis. Molecular cancer therapeutics 21 (8) (2022)
Heidi S Donovan, Susan M Sereika, Lari B Wenzel, Robert P Edwards, Judith E Knapp, Susan H Hughes, Mary C Roberge, Teresa Hagan Thomas, Sara Jo Klein, Michael B Spring, Susan Nolte, Lisa M Landrum, A Catherine Casey, David G Mutch, Robert L DeBernardo, Carolyn Y Muller, Stephanie A Sullivan, Sandra E Ward
Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (13) (2022)
Kristina W W Thiel, Eric J Devor, Virginia L Filiaci, David G Mutch, Katherine Moxley, Angeles A Secord, Krishnansu S Tewari, Megan E McDonald, Cara A Mathews, Casey Cosgrove, Summer Dewdney, Carol Aghajanian, Megan I Samuelson, Heather A Lankes, Robert A Soslow, Kimberly Kay Leslie
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (28) (2022)
Mary M Mullen, Elena Lomonosova, Michael D Toboni, Alyssa Oplt, Emily Cybulla, Barbara Blachut, Peinan Zhao, Hollie Noia, Daniel Wilke, Erinn B Rankin, Lindsay M Kuroki, Andrea R Hagemann, Ian S Hagemann, Carolyn K McCourt, Premal H Thaker, David G Mutch, Matthew A Powell, Nima Mosammaparast, Alessandro Vindigni, Katherine C Fuh
GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress. Molecular cancer research : MCR (2021)
Chenxuan Wang, Jessica Murphy, Kerri Z Delaney, Natalie Khor, José A Morais, Michael A Tsoukas, Dana E Lowry, David G Mutch, Sylvia Santosa
Association between rs174537 FADS1 polymorphism and immune cell profiles in abdominal and femoral subcutaneous adipose tissue: an exploratory study in adults with obesity. Adipocyte 10 (1) (2021)
Neeraj K Aryal, Vinod Pant, Amanda R Wasylishen, Bobbie J Rimel, Laura Baseler, Adel K El-Naggar, David G Mutch, Paul J Goodfellow, Swathi Arur, Guillermina Lozano
Dicer1 Phosphomimetic Promotes Tumor Progression and Dissemination. Cancer research 79 (10) (2019)
Peri H Fenwick, Khursheed Jeejeebhoy, Rupinder Dhaliwal, Dawna Royall, Paula Brauer, Angelo Tremblay, Doug Klein, David G Mutch
Lifestyle genomics and the metabolic syndrome: A review of genetic variants that influence response to diet and exercise interventions. Critical reviews in food science and nutrition 59 (13) (2018)
Elie Chamoun, David G Mutch, Emma Allen-Vercoe, Andrea C Buchholz, Alison M Duncan, Lawrence L Spriet, Jess Haines, David W L Ma, null null
A review of the associations between single nucleotide polymorphisms in taste receptors, eating behaviors, and health. Critical reviews in food science and nutrition 58 (2) (2017)
Hana Janouskova, Geniver El Tekle, Elisa Bellini, Namrata D Udeshi, Anna Rinaldi, Anna Ulbricht, Tiziano Bernasocchi, Gianluca Civenni, Marco Losa, Tanya Svinkina, Craig M Bielski, Gregory V Kryukov, Luciano Cascione, Sara Napoli, Radoslav I Enchev, David G Mutch, Michael E Carney, Andrew Berchuck, Boris J N Winterhoff, Russell R Broaddus, Peter Schraml, Holger Moch, Francesco Bertoni, Carlo V Catapano, Matthias Peter, Steven A Carr, Levi A Garraway, Peter J Wild, Jean-Philippe P Theurillat
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors. Nature medicine 23 (9) (2017)